VB15010
VB15010 is a small-molecule inhibitor from Zhejiang Yangli Pharmaceutical Technology Co., Ltd., in registered phase 2 trials for ovarian cancer, prostate cancer, pancreatic ductal adenocarcinoma.
Overview
VB15010 is listed on ClinicalTrials.gov as an intervention in 1 registered phase 2 trial sponsored by Zhejiang Yangli Pharmaceutical Technology Co., Ltd., in ovarian cancer, prostate cancer, pancreatic ductal adenocarcinoma, biliary tract cancer, colorectal cancer. Described in the registry record as a oral parp1 inhibitor; the trial entries below carry the sponsor's wording. OnCo records the agent from the registry alone; approvals, results and the sponsor's own description will follow as they are published.
Described in the registry record as a oral parp1 inhibitor; the trial entries below carry the sponsor's wording.
1.VB15010 slips into a pocket on its target.
Trials
topTrials recruiting now
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Landmark trials
Latest papers
topQuery for this drug: (TITLE:"VB15010" OR ABSTRACT:"VB15010") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about VB15010, not a curated reading list.
Similar pages
not linked directly; found by shared links- TreatmentNUV-1511
Shares Ovarian cancer, Pancreatic ductal adenocarcinoma, Prostate cancer and the tags pipeline, registry-only.
- TreatmentCT3001
Shares Pancreatic ductal adenocarcinoma, Colorectal cancer and the tags pipeline, registry-only.
- TrialA Study of DM002 in Patients With Advanced Solid Tumors
Shares Ovarian cancer, Pancreatic ductal adenocarcinoma, Prostate cancer, Colorectal cancer and the tag pipeline.
- TreatmentJMT203
Shares Pancreatic ductal adenocarcinoma, Colorectal cancer and the tags pipeline, registry-only.
- TreatmentVudalimab
Shares Ovarian cancer, Prostate cancer and the tags pipeline, registry-only.
- TrialA Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
Shares Ovarian cancer, Pancreatic ductal adenocarcinoma, Prostate cancer and the tag pipeline.
- TreatmentTILT-123
Shares Ovarian cancer and the tags pipeline, registry-only.
- TreatmentAZD8421
Shares Ovarian cancer and the tags pipeline, registry-only.